Debbie Robbrecht (@DebbieRobbrecht) profile picture

Debbie Robbrecht

@DebbieRobbrecht

Medical oncologist @ErasmusOncology

Joined April 2019
  • Tweets30
  • Following20
  • Followers36
1Media
Photo by Debbie Robbrecht (@DebbieRobbrecht)
Welcome you all to the sunny ☀️ and really hot Madrid!!! Lovely discussion about #bladdercancer Very happy to have you all here!!! @amerseburger @dralvaropinto @APoprach @laconss @fcala4 @DebbieRobbrecht
Image from Enrique Grande (@drenriquegrande)
1
4
32
Debbie Robbrecht retweeted
The Lancet (@TheLancet) profile picture
The Lancet
@TheLancet4 Jun 2020
Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet hubs.ly/H0r7gh50
Image from The Lancet (@TheLancet)
1,266
6,139
3,474
8,483
Debbie Robbrecht retweeted
Jessica van der Bol (@dokterJes) profile picture
Jessica van der Bol@dokterJes29 May 2020
Geriatrician-led CGA + intervention integraded with usual oncological care leads to better quality of life, less unplanned hospital admissions and less treatment discontinuation in older patient receiving #chemotherapy. Nice work from @KhengSoo1 #VirtualASCO #ASCO20 #GeriONC
Image from Jessica van der Bol (@dokterJes)
Image from Jessica van der Bol (@dokterJes)
10
1
16
Een thread over de nieuwe mogelijkheid om uitgebreide #DNA diagnostiek te ondergaan bij @ErasmusOncology. Wij geloven dat #zorgopmaat de toekomst heeft voor patiënten met #kanker
1
5
4
Now this is exciting. Kras G12c inhibitor. Genuinely seems to be well tolerated and exciting activity especially in #LCSM.
Image from Alastair Greystoke (@AlastairGreyst2)
Image from Alastair Greystoke (@AlastairGreyst2)
Image from Alastair Greystoke (@AlastairGreyst2)
Image from Alastair Greystoke (@AlastairGreyst2)
1
16
2
38
Blijft ‘n fascinerend fenomeen: Sonja Bakker en waarom mensen er steeds weer intuinen. Stevig commentaar in @volkskrant vandaag. Ons boek #VETbelangrijk (co-auteur @BoonMariette) wordt ook besproken, dat volgens de VK ‘wél hout snijdt’ en nog steeds in bestsellerlijsten staat.
Image from Liesbeth van Rossum (@EFCvanRossum)
1
14
23
Important reminder: lymph node progression under #immunotherapy may not be tumor progression. Specially relevant in the neoadjuvant setting. Why #pathology matters. #ASCO19 #LCSM – at Chicago, IL
Image from Dr. Antonio Calles 🫁🚭 (@Tony_Calles)
4
97
3
180
Our department is co-presenting at #ASCO2019. Intruiging data on the importance of #drugdelivery.
Florence Atrafi (@AtrafiFlorence) profile pictureFlorence Atrafi@AtrafiFlorence1 Jun 2019
Replying to @ASCO
@ASCO with two of our posters investigating CPC634 (docetaxel entrapped nanoparticles) #ASCO2019 #ASCO19 #ConquerCancer @ConquerCancerFd @martijn_lolkema
Image from Florence Atrafi (@AtrafiFlorence)
Image from Florence Atrafi (@AtrafiFlorence)
2
2
Debbie Robbrecht retweeted
JAMA Oncology (@JAMAOnc) profile picture
JAMA Oncology@JAMAOnc2 Jun 2019
CITN12 1st prospective study of #pembrolizumab in people living with #HIV & #cancer demonstrates safety and activity in several HIV-malignancies ja.ma/2MposfO #ASCO19
12
1
16
#JCOPO
Nathan A. Pennell MD, PhD, FASCO (@n8pennell) profile pictureNathan A. Pennell MD, PhD, FASCO
@n8pennell17 May 2019
Check our our new paper on cost of NGS versus single gene tests=> Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model #LCSM ascopubs.org/doi/full/10.120…
Image from Nathan A. Pennell MD, PhD, FASCO (@n8pennell)
1
7
13
Androgen deprivation therapy has been considered to be the primary standard of care for those with low volume metastatic prostate cancer. However, there's now another option. pcf.org/news/a-new-standard-…
1
14
1
18
Model-informed analyses of predicted exposure, efficacy and safety based on data from extensive clinical experience with nivolumab suggest that the benefit–risk profile of 480 mg Q4W regimen is comparable to the approved 3 mg/kg Q2W regimen #EditorsChoice bit.ly/2VIozT0
Image from Annals of Oncology (@Annals_Oncology)
3
5
Debbie Robbrecht retweeted
Lars Dyrskjøt (@LDyrskjot) profile picture
Lars Dyrskjøt@LDyrskjot6 May 2019
Our recent ctDNA results are now online. In a prospective study we show that plasma DNA identifies early relapse and correlates with treatment response in bladder cancer: ascopubs.org/doi/abs/10.1200… @Karin_Dem @EmilChristens @JBjerggaard @NateraGenetics @AUHdk @AarhusUni
Image from Lars Dyrskjøt (@LDyrskjot)
4
33
4
63
Measuring troponin for detection of immune checkpoint inhibitor-related myocarditis bit.ly/2Q238Lk #cardioonc #immunoonc
Image from Journal of Clinical Oncology (@JCO_ASCO)
10
13
Pre-operative #ctDNA predicts survival in high-risk stage III cutaneous melanoma patients bit.ly/2II8eeX
9
13
Debbie Robbrecht retweeted
DORATrial (@DoraTrial) profile picture
DORATrial@DoraTrial30 Apr 2019
Introducing @thePCCTC phase III #DORATrial testing radium-223 with docetaxel in men with castration-resistant prostate cancer and bone metastases (NCT03574571) clinicaltrials.gov/ct2/show/…
Image from DORATrial (@DoraTrial)
8
10
In 2017 bezochten 198 patiënten het Blaaskankercentrum voor een multidisciplinair behandelplan. In animaties laten wij zien wat de uitkomsten waren in 2017 #transparant #blaaskanker cc ⁦@SjoerdKlaver⁩ ⁦@IKNL⁩ ⁦@joostboormans⁩ oncologienetwerkzuidwest.nl/…
4
3
Load more